By Michelle Llamas 
Men who take testosterone supplements for cardiovascular, sexual and physical function probably won’t see any benefits, researchers report. Researchers at Georgetown University collected data that suggests testosterone replacement therapy has no beneficial effect on health...
By Michelle Llamas 
Johnson & Johnson’s Janssen Pharmaceuticals knew about a faulty device and data in a Xarelto (rivaroxaban) regulatory trial that suggests they put participants at risk, The BMJ reports. Janssen withheld data about problems with the INRation device from the U.S. Food and Drug...
By Michelle Llamas 
Patients who suffered trauma and received inferior vena cava (IVC) filters to prevent blood clots in the lungs had no survival advantage, researchers reported. The study published in JAMA Surgery showed no decrease in death rates in patients who received IVC filters to prevent...
By Michelle Llamas 
The U.S. Food and Drug Administration released a safety communication informing the public of stronger kidney injury warning labels on SGLT2 inhibitors that treat Type 2 diabetes, including J&J’s Invokana/Invokamet (Canagliflozin) and Farxiga/Xigduo XR. “Based on recent...
By Michelle Llamas 
The U.S. Food and Drug Administration warned that taking more than the recommended dose of the popular diarrhea medicine Imodium (loperamide) can cause severe heart problems and even lead to death. Pharmacists worry that some with opioid addiction are turning to the low cost...
By Michelle Llamas 
A new medical study showed that patients who took opioid painkillers three months after hip replacement surgery were more likely to need revision surgery at one and five years than those who stopped taking the drugs. Experts also worry about an increase in opioid overdoses....
By Michelle Llamas 
The U.S. Food and Drug Administration issued a Drug Safety Communication on May 18, 2016 warning that Type 2 diabetes medication Invokana (canagliflozin) could cause an increase in leg and foot amputations. The toes are the most affected. Johnson & Johnson’s Invokana is a...
By Michelle Llamas 
New research suggests that popular heartburn drugs called proton pump inhibitors (PPIs) such as Prevacid (lansoprazole), Prilosec (omeprazole) and Nexium (esomeprazole) may damage arteries leading to an increased risk of heart attack, kidney failure and dementia. In the 2016...
By Michelle Llamas 
In the wake of two multi-million dollar jury verdicts, Johnson & Johnson faces another wave of lawsuits filed by women and surviving members of families who claim the company’s talcum powder caused ovarian cancer. Plaintiff’s attorneys want the drug giant to pull its iconic... Page 5 of 17
The independent gateway for the orthopaedic community. Connecting professionals and patients since 1999.